MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aldern, K. A.
Right arrow Articles by Hostetler, K. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aldern, K. A.
Right arrow Articles by Hostetler, K. Y.

Vol. 63, Issue 3, 678-681, March 2003

Increased Antiviral Activity of 1-O-Hexadecyloxypropyl-[2-14C]cidofovir in MRC-5 Human Lung Fibroblasts Is Explained by Unique Cellular Uptake and Metabolism

Kathy A. Aldern, Stephanie L. Ciesla, Kristine L. Winegarden, and Karl Y. Hostetler

Department of Medicine, San Diego VA Healthcare System and the University of California, San Diego, La Jolla, California

Recently, there has been renewed interest in finding orally active drugs against smallpox. Cidofovir (CDV) given by parenteral injection has been shown to protect against lethal poxvirus infection. We have been interested in the synthesis and evaluation of orally active derivatives of CDV. Previous studies showed that the CDV and cyclic cidofovir (cCDV) analogs 1-O-hexa-decyloxypropyl-CDV (HDP-CDV) and 1-O-hexadecyloxypropyl-cCDV (HDP-cCDV), show >100-fold increases in antiviral activity versus the unmodified nucleosides against cells infected with orthopoxviruses, cowpox, and vaccinia virus. In contrast to CDV, HDP-CDV is orally bioavailable and has been reported to be orally active in lethal cowpox virus infection in mice. To assess the metabolic basis for the increased antiviral activity of HDP-CDV in vitro, we studied the cellular uptake and anabolic metabolism of 14C-labeled CDV, cCDV, and their alkoxyalkanol esters HDP-CDV and HDP-cCDV. HDP-CDV and HDP-cCDV were taken up rapidly by MRC-5 human lung fibroblasts in vitro, but uptake of CDV and cCDV was much slower. Analysis of cellular metabolites showed that levels of cidofovir diphosphate (CDV-DP), the active antiviral compound, were >100 times greater with HDP-CDV than levels observed with CDV. When cells were exposed to HDP-CDV, the intracellular half-life of CDV-DP was 10 days versus 2.7 days reported when cells are exposed to CDV. HDP-CDV seems to circumvent poor cellular uptake by rapid association with cellular membrane phospholipids, whereas CDV uptake proceeds via the slow process of fluid endocytosis.

Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
W. C. Magee, K. A. Aldern, K. Y. Hostetler, and D. H. Evans
Cidofovir and (S)-9-[3-Hydroxy-(2-Phosphonomethoxy)Propyl]Adenine Are Highly Effective Inhibitors of Vaccinia Virus DNA Polymerase When Incorporated into the Template Strand
Antimicrob. Agents Chemother., February 1, 2008; 52(2): 586 - 597.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. M. Adams, A. D. Rice, and R. W. Moyer
Rabbitpox Virus and Vaccinia Virus Infection of Rabbits as a Model for Human Smallpox
J. Virol., October 15, 2007; 81(20): 11084 - 11095.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
G. R. Painter, M. R. Almond, L. C. Trost, B. M. Lampert, J. Neyts, E. De Clercq, B. E. Korba, K. A. Aldern, J. R. Beadle, and K. Y. Hostetler
Evaluation of Hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)Propyl]- Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections
Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3505 - 3509.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
H. Choo, J. R. Beadle, E. R. Kern, M. N. Prichard, K. A. Keith, C. B. Hartline, J. Trahan, K. A. Aldern, B. E. Korba, and K. Y. Hostetler
Antiviral Activities of Novel 5-Phosphono-Pent-2-en-1-yl Nucleosides and Their Alkoxyalkyl Phosphonoesters
Antimicrob. Agents Chemother., February 1, 2007; 51(2): 611 - 615.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. Y. Hostetler, K. A. Aldern, W. B. Wan, S. L. Ciesla, and J. R. Beadle
Alkoxyalkyl esters of (s)-9-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine are potent inhibitors of the replication of wild-type and drug-resistant human immunodeficiency virus type 1 in vitro.
Antimicrob. Agents Chemother., August 1, 2006; 50(8): 2857 - 2859.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
P. Randhawa, N. A. Farasati, R. Shapiro, and K. Y. Hostetler
Ether Lipid Ester Derivatives of Cidofovir Inhibit Polyomavirus BK Replication In Vitro.
Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1564 - 1566.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Y. Hostetler, S. Rought, K. A. Aldern, J. Trahan, J. R. Beadle, and J. Corbeil
Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro
Mol. Cancer Ther., January 1, 2006; 5(1): 156 - 159.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
G. Yang, D. C. Pevear, M. H. Davies, M. S. Collett, T. Bailey, S. Rippen, L. Barone, C. Burns, G. Rhodes, S. Tohan, et al.
An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge
J. Virol., October 15, 2005; 79(20): 13139 - 13149.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. L. Williams-Aziz, C. B. Hartline, E. A. Harden, S. L. Daily, M. N. Prichard, N. L. Kushner, J. R. Beadle, W. B. Wan, K. Y. Hostetler, and E. R. Kern
Comparative Activities of Lipid Esters of Cidofovir and Cyclic Cidofovir against Replication of Herpesviruses In Vitro
Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3724 - 3733.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. Cheng, K. Y. Hostetler, J. Lee, H. J. Koh, J. R. Beadle, K. Bessho, M. Toyoguchi, K. Aldern, J.-M. Bovet, and W. R. Freeman
Characterization of a Novel Intraocular Drug-Delivery System Using Crystalline Lipid Antiviral Prodrugs of Ganciclovir and Cyclic Cidofovir
Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4138 - 4144.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. R. Kern, D. J. Collins, W. B. Wan, J. R. Beadle, K. Y. Hostetler, and D. C. Quenelle
Oral Treatment of Murine Cytomegalovirus Infections with Ether Lipid Esters of Cidofovir
Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3516 - 3522.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. Bray and C. J. Roy
Antiviral prophylaxis of smallpox
J. Antimicrob. Chemother., July 1, 2004; 54(1): 1 - 5.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D. C. Quenelle, D. J. Collins, W. B. Wan, J. R. Beadle, K. Y. Hostetler, and E. R. Kern
Oral Treatment of Cowpox and Vaccinia Virus Infections in Mice with Ether Lipid Esters of Cidofovir
Antimicrob. Agents Chemother., February 1, 2004; 48(2): 404 - 412.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
E. De Clercq
Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections
Clin. Microbiol. Rev., October 1, 2003; 16(4): 569 - 596.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics